Anti-PD1 monotherapy in hepatocellular carcinoma: a step forward or already behind?

被引：2
|
作者：
Catanese, Silvia [1 ,2 ]
Lordick, Florian [2 ]
机构：
[1] Univ Pisa, Azienda Osped Univ Pisana AOUP, Dept Med Oncol, Pisa, Italy
[2] Univ Leipzig, Univ Canc Ctr Leipzig UCCL, Med Ctr, Dept Med Oncol Gastroenterol Hepatol Pulmonol & I, Leipzig, Germany
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2020年 / 8卷 / 24期
关键词：
2ND-LINE THERAPY; DOUBLE-BLIND; OPEN-LABEL; PHASE-III; SORAFENIB; MULTICENTER; CAMRELIZUMAB;
D O I：
10.21037/atm-20-4438
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Molecular markers of response to anti-pd1 therapy in advanced hepatocellular carcinoma
    Haber, Philipp
    Torres-Martin, Miguel
    Andreu-Oller, Carmen
    Puigvehi, Marc
    Maeda, Miho
    Castet, Florian
    Radu, Pompilia
    Dufour, Jean-Francois
    Verslype, Chris
    Czauderna, Carolin
    Marquardt, Jens U.
    Galle, Peter
    Vogel, Arndt
    Bathon, Melanie
    Meyer, Tim
    Labgaa, Ismail
    Digkilia, Antonia
    Roberts, Lewis
    Ali, Mohamed A. Mohamed
    Minguez, Beatriz
    Citterio, Davide
    Mazzaferro, Vincenzo
    Finkelmeier, Fabian
    Trojan, Joerg
    Oezdirik, Burcin
    Mueller, Tobias
    Schmelzle, Moritz
    Bejjani, Anthony
    Finn, Richard
    Thung, Swan N.
    Villanueva, Augusto
    Sia, Daniela
    Llovet, Josep M.
    JOURNAL OF HEPATOLOGY, 2021, 75 : S521 - S522
  • [2] Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma
    Haber, Philipp K.
    Castet, Florian
    Torres-Martin, Miguel
    Andreu-Oller, Carmen
    Puigvehi, Marc
    Miho, Maeda
    Radu, Pompilia
    Dufour, Jean-Francois
    Verslype, Chris
    Zimpel, Carolin
    Marquardt, Jens U.
    Galle, Peter R.
    Vogel, Arndt
    Bathon, Melanie
    Meyer, Tim
    Labgaa, Ismail
    Digklia, Antonia
    Roberts, Lewis R.
    Ali, Mohamed A. Mohamed
    Minguez, Beatriz
    Citterio, Davide
    Mazzaferro, Vincenzo
    Finkelmeier, Fabian
    Trojan, Joerg
    Ozdirik, Burcin
    Mueller, Tobias
    Schmelzle, Moritz
    Bejjani, Anthony
    Sung, Max W.
    Schwartz, Myron E.
    Finn, Richard S.
    Thung, Swan
    Villanueva, Augusto
    Sia, Daniela
    Llovet, Josep M.
    GASTROENTEROLOGY, 2023, 164 (01) : 72 - 88.e18
  • [3] Initial experience of anti-PD1 therapy with nivolumab in advanced hepatocellular carcinoma
    Feng, Duan
    Hui, Xie
    Shi-Chun, Lu
    Yan-Hua, Bai
    Li, Cui
    Xiao-Hui, Li
    Jie-Yu, Yan
    ONCOTARGET, 2017, 8 (57) : 96649 - 96655
  • [4] MOLECULAR MARKERS OF RESPONSE TO ANTI-PD1 THERAPY IN ADVANCED HEPATOCELLULAR CARCINOMA
    Haber, Philipp K.
    Castet, Florian
    Torres-Martin, Miguel
    Andreu-Oller, Carmen
    Puigvehi, Marc
    Maeda, Miho
    Radu, Pompilia
    Dufour, Jean-Francois
    Verslype, Chris
    Czauderna, Carolin
    Marquardt, Jens U.
    Galle, Peter R.
    Vogel, Arndt
    Bathon, Melanie
    Meyer, Timothy
    Labgaa, Ismail
    Digklia, Antonia
    Roberts, Lewis R.
    Ali, Mohamed Mohamed
    Minguez, Beatriz
    Citterio, Davide
    Mazzaferro, Vincenzo
    Finkelmeier, Fabian
    Trojan, Jorg
    Ozdirik, Burcin
    Mueller, Tobias
    Schmelzle, Moritz
    Bejjani, Anthony
    Sung, Max W.
    Schwartz, Myron E.
    Finn, Richard
    Thung, Swan N.
    Villanueva, Augusto
    Sia, Daniela
    Llovet, Josep M.
    HEPATOLOGY, 2021, 74 : 109A - 110A
  • [5] Limited Impact of Anti-PD-1/PD-L1 Monotherapy for Hepatocellular Carcinoma
    Kudo, Masatoshi
    LIVER CANCER, 2020, 9 (06) : 629 - 639
  • [6] Therapeutic Effects of Anti-PD1 Immunotherapy on Hepatocellular Carcinoma Under Administration of Tacrolimus
    Hsu, Yu-Chen
    Chen, Chien-Hung
    Huang, Hui-Fu
    Lee, Ying-Te
    Wu, Meng-Chuan
    Su, Chien-Wen
    Chou, Huei-Chi
    Wang, Li-Fang
    Lee, Hsuan-Shu
    Lin, Shu-Wha
    Hsu, Ping-Ning
    Wu, Yao-Ming
    Sheu, Jin-Chuan
    Weng, Meng-Tzu
    TRANSPLANTATION, 2023, 107 (07) : 1492 - 1501
  • [7] A FAK Inhibitor Boosts Anti-PD1 Immunotherapy in a Hepatocellular Carcinoma Mouse Model
    Wei, Yuhua
    Wang, Yufeng
    Liu, Nanbin
    Qi, Ran
    Xu, Yan
    Li, Kun
    Feng, Yu
    Shi, Baomin
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [8] Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma.
    Haber, Philipp K.
    Torres-Martin, Miguel
    Dufour, Jean-Francois
    Verslype, Chris
    Marquardt, Jens
    Galle, Peter R.
    Vogel, Arndt
    Meyer, Tim
    Labgaa, Ismail
    Roberts, Lewis R.
    Minguez, Beatriz
    Mazzaferro, Vincenzo
    Finkelmeier, Fabian
    Muller, Tobias
    Schmelzle, Moritz
    Finn, Richard S.
    Thung, Swan
    Villanueva, Augusto
    Sia, Daniela
    Llovet, Josep M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma
    Zhang, Rui-Jun
    Zhou, Hong-Mei
    Lu, Hai-Yan
    Yu, Hong-Ping
    Tang, Wei-Zhong
    Qiu, Mo-Qin
    Yan, Liu-Ying
    Long, Mei-Ying
    Su, Ting-Shi
    Xiang, Bang-De
    He, Mei-Ling
    Wang, Xiao-Ting
    Liang, Shi-Xiong
    Li, Jian-Xu
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [10] Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma
    Rui-Jun Zhang
    Hong-Mei Zhou
    Hai-Yan Lu
    Hong-Ping Yu
    Wei-Zhong Tang
    Mo-Qin Qiu
    Liu-Ying Yan
    Mei-Ying Long
    Ting-Shi Su
    Bang-De Xiang
    Mei-Ling He
    Xiao-Ting Wang
    Shi-Xiong Liang
    Jian-Xu Li
    Radiation Oncology, 18
12345